Evaluation of Novel Small Molecule Inhibitors of SARS-CoV-2 Developed by Eisbach Bio

Project: Other project

Project Details

StatusActive
Effective start/end date12/10/2011/15/22

Funding

  • Eisbach Bio GmbH: $21,600.00